Announcing the successful applicants of the SPHERE/Sydney Cancer Partners Strategic Enhancement Grant
Professor Jeff Holst from UNSW Sydney and Associate Professor James Wilmott from the Melanoma Institute Australia & The University of Sydney will co-lead a project to validate a physiological ex vivo platform to rapidly test novel immunotherapy combinations in patient tumours.
Professor Hilda Pickett from the Children’s Medical Research Institute & The University of Sydney and Associate Professor Liz Caldon from the Garvan Institute of Medical Research are coming together to lead a program investigating telomere remodelling in drug resistant breast cancer.
Each team has been awarded $280,000 over two years with funding from the Cancer Institute NSW’s Translational Cancer Research Capacity Building grants held by Sydney Health Partners and Maridulu Budyari Gumal (SPHERE).